InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: frosr6 post# 42288

Wednesday, 10/21/2015 11:07:25 AM

Wednesday, October 21, 2015 11:07:25 AM

Post# of 144814
Fros, I wouldn't bullshit you. The first time we learned how TD2 got involved was back in 2014 in this radio interview with Ken Waggoner and Dr Crabtree. Ken told us that Dr Von Hoff contacted him via email. And it was Dr Von Hoff who wanted to do trials with Cell in a Box for pain and malignant ascites. "It was never our idea", he said... Listen circa 10:10 in this radio interview. http://www.stockmarketmediagroup.com/wp-content/uploads/2014/06/NVLX-CEO-COO-Interview.mp3

Like you, many refused to believe what our CEO said so when we did the corporate interview recently, we learned the same thing. The president and CEO of TD2, Stephen Gately told us that actually Dr Von Hoff saw the data and reached out to KW.

Circa 17:00 minutes on the video... http://www.pharmacytebiotech.com/pharmacyte-biotech-corporate-video-june-1-2015/

So, we would have been crazy not to select TD2 as our US CRO. Dr Von Hoff wanting to work with Cell in a Box... Yes we selected them...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News